BE1003021A3 - Compositions pharmaceutiques agissant en particulier sur le systeme cardiaque et cardiovasculaire et procede pour les preparer. - Google Patents
Compositions pharmaceutiques agissant en particulier sur le systeme cardiaque et cardiovasculaire et procede pour les preparer. Download PDFInfo
- Publication number
- BE1003021A3 BE1003021A3 BE8900321A BE8900321A BE1003021A3 BE 1003021 A3 BE1003021 A3 BE 1003021A3 BE 8900321 A BE8900321 A BE 8900321A BE 8900321 A BE8900321 A BE 8900321A BE 1003021 A3 BE1003021 A3 BE 1003021A3
- Authority
- BE
- Belgium
- Prior art keywords
- cardiac
- preparing
- pharmaceutical compositions
- cardiovascular system
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
Abstract
L'invention concerne des compositions pharmaceutiques agissant en particulier sur les états thrombo-emboliques du système cardiaque et cardiovasculaire, qui comprennent 0,5 à 50 % en masse d'un micro-organisme contenant du sélénium ainsi que 99,5 à 50 % en masse d'acides gras en C18-24 contenant aux moins deux liaisons insaturées ou leurs dérivés, éventuellement en mélange avec des véhicules et/ou des additifs couramment utilisés dans l'industrie pharmaceutique et éventuellement avec des antioxydants. En outre, l'invention concerne un procédé pour préparer ces compositions.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU881484A HU210122B (en) | 1988-03-23 | 1988-03-23 | Process for production of composition against thromboembolytic conditions of circulating system and heart |
Publications (1)
Publication Number | Publication Date |
---|---|
BE1003021A3 true BE1003021A3 (fr) | 1991-10-29 |
Family
ID=10954680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE8900321A BE1003021A3 (fr) | 1988-03-23 | 1989-03-23 | Compositions pharmaceutiques agissant en particulier sur le systeme cardiaque et cardiovasculaire et procede pour les preparer. |
Country Status (15)
Country | Link |
---|---|
JP (1) | JPH0222228A (fr) |
KR (1) | KR890014104A (fr) |
BE (1) | BE1003021A3 (fr) |
CA (1) | CA1319607C (fr) |
CH (1) | CH677732A5 (fr) |
DE (1) | DE3909707A1 (fr) |
ES (1) | ES2014060A6 (fr) |
FI (1) | FI891438A (fr) |
FR (1) | FR2628972B1 (fr) |
GB (1) | GB2216421A (fr) |
HU (1) | HU210122B (fr) |
IT (1) | IT1229205B (fr) |
LU (1) | LU87488A1 (fr) |
NL (1) | NL8900742A (fr) |
SE (1) | SE8901041L (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3114198B2 (ja) * | 1990-11-06 | 2000-12-04 | ソニー株式会社 | 電子機器 |
KR19990015198A (ko) * | 1997-08-02 | 1999-03-05 | 손남율 | 식물성 항생제 |
BE1012495A3 (fr) | 1999-03-02 | 2000-11-07 | Messadek Jallal | La glycine-betaine pour son usage antithrombotique. |
US7608640B2 (en) | 1999-03-02 | 2009-10-27 | Jallal Messadek | Glycine betaine and its use |
GB2363331B (en) * | 2000-06-17 | 2003-02-05 | Raymond Clifford Noble | Supplement to enhance fertility |
FR2816211B1 (fr) * | 2000-11-08 | 2005-04-01 | Brif | Nouvelles compositions dietetiques et ou/cosmetiques pour ameliorer la secheresse des muqueuses |
BE1015608A6 (fr) | 2003-07-15 | 2005-06-07 | Messadek Jallal | Traitement des arterites. |
US8729124B2 (en) | 2002-03-05 | 2014-05-20 | Pronova Biopharma Norge As | Use of EPA and DHA in secondary prevention |
AU2003229993B2 (en) * | 2002-05-03 | 2008-07-24 | Pronova Biopharma Norge As | Use of EPA and DHA in secondary prevention |
US20040076695A1 (en) | 2002-07-08 | 2004-04-22 | Advanced Vision Research | EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
US20060233863A1 (en) | 2003-02-10 | 2006-10-19 | Enzymotec Ltd. | Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy |
FR2863170A1 (fr) * | 2003-12-08 | 2005-06-10 | Nicolai Christian Paul Xavier | Composition regeneratrice et regulatrice de l'appareil digestif |
EP1776159A1 (fr) * | 2004-08-09 | 2007-04-25 | Enzymotec Ltd. | Produits alimentaires pour diabetiques |
KR101323513B1 (ko) | 2004-08-10 | 2013-10-29 | 엔지모테크 리미티드 | 의학적 증상의 치료에서의 사용을 위한 피토스테롤에스테르(들) 및 1,3-디글리세라이드(들)의 혼합물 |
WO2006050581A2 (fr) | 2004-11-10 | 2006-05-18 | Jallal Messadek | Betaine en tant qu'agent de lutte contre des maladies transmises par des arthropodes ou des moustiques |
HU227588B1 (hu) * | 2004-12-03 | 2011-09-28 | Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft | Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény |
EP2242489A1 (fr) | 2005-02-15 | 2010-10-27 | Jallal Messadek | Compositions therapeutiques combinees et leurs procedes d utilisation |
ATE540690T1 (de) | 2005-04-27 | 2012-01-15 | Jallal Messadek | Insulinkombinationen |
ITMI20052483A1 (it) * | 2005-12-23 | 2007-06-24 | Novamont Spa | Esche biodegradabili |
FR2935394B1 (fr) | 2008-08-29 | 2013-03-08 | Eco Solution | Microorganismes photosynthetiques enrichis en selenium organique a partir de composes seleno-hydroxyacides et leurs applications en nutrition, cosmetique et pharmacie |
FR2935393B1 (fr) | 2008-08-29 | 2012-08-24 | Tetrahedron | Bacteries et levures enrichies en selenium organique a partir de composes seleno-hydroxyacides et leurs applications en nutrition, cosmetique et pharmacie |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2148713A (en) * | 1983-10-24 | 1985-06-05 | Century Lab Inc | Pharmaceutical composition and food product comprising higher fatty acids |
FR2612373A1 (fr) * | 1987-03-18 | 1988-09-23 | Caola Kozmetikai | Compositions dietetiques et procede pour leur preparation |
FR2612399A1 (fr) * | 1987-03-18 | 1988-09-23 | Caola Kozmetikai | Compositions pharmaceutiques agissant sur le coeur et le systeme cardiovasculaire et procede pour leur preparation |
GB2216418A (en) * | 1988-03-09 | 1989-10-11 | Biorex Kft | Antiviral and immunostimulating compositions comprising amino acids and polyunsaturated higher fatty acids. |
-
1988
- 1988-03-23 HU HU881484A patent/HU210122B/hu unknown
-
1989
- 1989-03-20 CH CH1014/89A patent/CH677732A5/de not_active IP Right Cessation
- 1989-03-21 ES ES8901022A patent/ES2014060A6/es not_active Expired - Fee Related
- 1989-03-23 IT IT8919876A patent/IT1229205B/it active
- 1989-03-23 KR KR1019890003678A patent/KR890014104A/ko not_active Application Discontinuation
- 1989-03-23 FI FI891438A patent/FI891438A/fi not_active Application Discontinuation
- 1989-03-23 BE BE8900321A patent/BE1003021A3/fr not_active IP Right Cessation
- 1989-03-23 FR FR8903812A patent/FR2628972B1/fr not_active Expired - Fee Related
- 1989-03-23 SE SE8901041A patent/SE8901041L/xx not_active Application Discontinuation
- 1989-03-23 NL NL8900742A patent/NL8900742A/nl not_active Application Discontinuation
- 1989-03-23 DE DE3909707A patent/DE3909707A1/de not_active Withdrawn
- 1989-03-23 JP JP1069437A patent/JPH0222228A/ja active Pending
- 1989-03-23 LU LU87488A patent/LU87488A1/fr unknown
- 1989-03-23 GB GB8906856A patent/GB2216421A/en not_active Withdrawn
- 1989-03-23 CA CA000594762A patent/CA1319607C/fr not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2148713A (en) * | 1983-10-24 | 1985-06-05 | Century Lab Inc | Pharmaceutical composition and food product comprising higher fatty acids |
FR2612373A1 (fr) * | 1987-03-18 | 1988-09-23 | Caola Kozmetikai | Compositions dietetiques et procede pour leur preparation |
FR2612399A1 (fr) * | 1987-03-18 | 1988-09-23 | Caola Kozmetikai | Compositions pharmaceutiques agissant sur le coeur et le systeme cardiovasculaire et procede pour leur preparation |
GB2216418A (en) * | 1988-03-09 | 1989-10-11 | Biorex Kft | Antiviral and immunostimulating compositions comprising amino acids and polyunsaturated higher fatty acids. |
Also Published As
Publication number | Publication date |
---|---|
CA1319607C (fr) | 1993-06-29 |
CH677732A5 (fr) | 1991-06-28 |
SE8901041D0 (sv) | 1989-03-23 |
HUT60436A (en) | 1992-09-28 |
GB8906856D0 (en) | 1989-05-10 |
NL8900742A (nl) | 1989-10-16 |
FR2628972B1 (fr) | 1994-09-23 |
IT8919876A0 (it) | 1989-03-23 |
ES2014060A6 (es) | 1990-06-16 |
HU210122B (en) | 1995-02-28 |
DE3909707A1 (de) | 1989-10-05 |
GB2216421A (en) | 1989-10-11 |
SE8901041L (sv) | 1989-09-24 |
FI891438A0 (fi) | 1989-03-23 |
LU87488A1 (fr) | 1990-10-02 |
KR890014104A (ko) | 1989-10-21 |
IT1229205B (it) | 1991-07-25 |
JPH0222228A (ja) | 1990-01-25 |
FI891438A (fi) | 1989-09-24 |
FR2628972A1 (fr) | 1989-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE1003021A3 (fr) | Compositions pharmaceutiques agissant en particulier sur le systeme cardiaque et cardiovasculaire et procede pour les preparer. | |
HUT70449A (en) | Highly concentrated immunoglobulin preparation and method for its production | |
BE1002890A3 (fr) | Compositions pharmaceutiques antivirales et immunostimulantes et procede pour les preparer. | |
HK1002633A1 (en) | Arysulfonamido-substituted hydroxamix acids | |
BE902874A (fr) | Compositions therapeutiques et procede pour le traitement ou la prevention des maladies provoquees par le paf-acether | |
FR2440371A1 (fr) | Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer | |
FR2714059B1 (fr) | Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. | |
FR2449697A1 (fr) | Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant | |
BE1002428A3 (fr) | Compositions pharmaceutiques agissant sur le coeur et le systeme cardiovasculaire et procede pour leur preparation. | |
FR2398112A1 (fr) | Procede en vue d'ameliorer l'arome et/ou la mousse du vin mousseux, du vin champagnise ou du vin petillant et produits ainsi ameliores | |
FR2392068A1 (fr) | Procede de production d'une charge particulaire enrobee pour polymeres organiques | |
BE1002429A3 (fr) | Compositions dietetiques et procede pour leur preparation. | |
ATE41785T1 (de) | Membranoese polysaccharide, verwendbar insbesondere als arzneimittel und verfahren zu ihrer herstellung. | |
NZ242155A (en) | 4-aminobutoxyphosphonic acid derivatives, their preparation using streptomyces platensis, and pharmaceutical compositions | |
BE901433A (fr) | Composition pharmaceutique stable pour le traitement de la cetose et procede pour la preparer. | |
FR2456474A1 (fr) | Agent d'entretien pouvant etre pulverise a partir d'un conteneur, et procede pour l'entretien d'instruments medicaux, notamment de dentisterie avec un tel agent | |
BE1001522A3 (fr) | Compositions cosmetiques regenerant la peau et leur procede de preparation. | |
FR2642423B1 (fr) | Procede de preparation d'alkyldiethanolamides gras purifies, les produits obtenus et leurs utilisations | |
KR950014314A (ko) | 하이드록실화되거나 산화된 지질 측쇄를 갖는 모에노마이신 분해 생성물 및 모에노마이신 동족체, 이들 화합물의 제조 방법 및 용도 | |
DE69313634D1 (de) | Elastosole sowie deren herstellung, verwendung und produkte | |
DE59309188D1 (de) | 2-arylpropionsäure-zubereitungen und verfahren zu ihrer herstellung | |
AU4347389A (en) | Novel s-timolol derivative and process for its preparation | |
FR2372137A1 (fr) | Procede de transformation microbiologique de steroides en 3aa- h-4a-(acide 3'-propionique)-7ab-methylhexahydro-1,5-indanedione | |
FR2422403A1 (fr) | Compositions therapeutiques diuretiques a effet rapide, a base d'acide 4-chloro-n-furfuryl-5-sulfamoylanthranilique et de composes de pteridine | |
EP0260064A3 (en) | Process for separating organic material from particulate solids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: BIOREX KFT Effective date: 19960331 |